Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Belite Bio Inc increased its cash reserves by 109.45%, or 46.07m. Cash Flow from Financing totalled 75.96m or -- of revenues. In addition the company used 29.84m for operations while cash used for investing totalled 63.00k.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 3.74 |
---|---|
Tangible book value per share | 3.74 |
More ▼
Balance sheet in USDView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼